Open Access Open Access  Restricted Access Subscription or Fee Access

A systematic review of yoga and schizophrenia spectrum disorders: Implications for recreational therapy practitioners

Emilie V. Adams, MS, CTRS, C-IAYT, Jasmine Townsend, PhD, CTRS

Abstract


Schizophrenia spectrum disorders (SSDs) are a group of mental illnesses characterized by hallucinations, delusions, disorganized thought; they are often accompanied by cognitive dysfunction, social skills deficits, and low volition. This article reviews the extant literature on the efficacy of using yoga as an adjunct therapy to supplement standard pharmacotherapy and psychotherapy in the treatment and management of SSD. The 16 studies reviewed indicate yoga may be an effective intervention for increasing global cognitive functioning, decreasing psychotic symptoms, and improving quality of life for clients with SSD. Recommendations for integration of yoga into a Recreation Therapy program are outlined.


Keywords


recreation therapy, yoga, schizophrenia, stress vulnerability model, complementary medicine

Full Text:

PDF

References


van Os J, Kenis G, Rutten BPF: The environment and schizophrenia. Nature. 2010; 468(7321): 203-212. doi:10.1038/nature09563.

Ritsner MR: Handbook of Schizophrenia Spectrum Disorders. London: Springer Netherlands, 2014.

Veerman SRT, Schulte PFJ, de Haan L: Treatment for negative symptoms in schizophrenia: A comprehensive review. Drugs. 2017; 77(13): 1423-1459. doi:10.1007/s40265-017-0789-y.

Tsapakis EM, Dimopoulou T, Tarazi FI: Clinical management of negative symptoms of schizophrenia: An update. Pharmacol Ther. 2015; 153: 135-147. doi:10.1016/J.PHARMTHERA.2015.06.008.

Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13(2): 261-276. doi:10.1093/schbul/13.2.261.

Buckley PF, Miller BJ, Lehrer DS, et al.: Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009; 35(2): 383-402. doi:10.1093/schbul/sbn135.

Grant P, Reisweber J, Luther L, et al.: Successfully breaking a 20-year cycle of hospitalizations with recovery-oriented cognitive therapy for schizophrenia. Psychol Serv. 2014; 11(2): 125-133. doi:10.1037/a0033912.

Wykes T, Huddy V, Cellard C, et al.: A meta-analysis of cognitive remediation for schizophrenia: Methodology and effect sizes. Am J Psychiatry. 2011; 168(5): 472-485. doi:10.1176/appi.ajp.2010.10060855.

Kirschner M, Aleman A, Kaiser S: Secondary negative symptoms—A review of mechanisms, assessment and treatment. Schizophr Res. 2017; 186: 29-38. doi:10.1016/j.schres.2016.05.003.

Zygmunt A, Olfson M, Boyer CA, et al.: Interventions to improve medication adherence in schizophrenia. Am J Psychiatry. 2002; 159(10): 1653-1664.

Wykes T, Evans J, Paton C, et al.: What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication. Psychol Med. 2017; 47(13): 2369-2378. doi:10.1017/S0033291717000903.

Higashi K, Medic G, Littlewood KJ, et al.: Medication adherence in schizophrenia: Factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol. 2013; 3(4): 200-218. doi:10.1177/2045125312474019.

Mondino M, Brunelin J, Palm U, et al.: Transcranial direct current stimulation for the treatment of refractory symptoms of schizophrenia. Current evidence and future directions. Curr Pharm Des. 2015; 21(23): 3373-3383.

Elkis H: Treatment-resistant schizophrenia. Psychiatr Clin North Am. 2007; 30(3): 511-533. doi:10.1016/j.psc.2007.04.001.

Zubin J, Spring B: Vulnerability: A new view of schizophrenia. J Abnorm Psychol. 1977; 86(2): 103.

Nuechterlein KH, Dawsom ME: A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull. 1984; 10(2): 300.

Nuechterlein KH, Dawson ME, Ventura J, et al.: The vulnerability/stress model of schizophrenic relapse: A longitudinal study. Acta Psychiatr Scand Suppl. 1994; 89(382): 58-64. doi:10.1111/j.1600-0447.1994.tb05867.x.

Garrett M, Turkington D: CBT for psychosis in a psychoanalytic frame. Psychosis. 2011; 3(1): 2-13.

Kapur S: Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003; 160(1): 13-23.

Wiersma D, Jenner JA, Nienhuis FJ, et al.: Hallucination focused integrative treatment improves quality of life in schizophrenia patients. Acta Psychiatr Scand. 2004; 109(3): 194-201. doi:10.1046/j.0001-690X.2003.00237.x.

Crone D, Guy H: ‘I know it is only exercise, but to me it is something that keeps me going’: A qualitative approach to understanding mental health service users’ experiences of sports therapy. Int J Ment Health Nurs. 2008; 17(3): 197-207. doi:10.1111/j.1447-0349.2008.00529.x.

Firth J, Stubbs B, Rosenbaum S, et al.: Aerobic exercise improves cognitive functioning in people with schiozphrenia: A systematic review and meta-analysis. Schizophr Bull. 2017; 43(3): 546-556.

McCormick BP, Snethen G, Smith RL, et al.: Active leisure in the emotional experience of people with schizophrenia. Ther Recreation J. 2012; 46(3): 179-190.

Alysha A, Walter MC, Bryan P, et al.: Aquatic activity and emotional experience in adults with severe mental illness. Am J Recreat Ther. 2017; 13(3): 7-12. doi:10.5055/AJRT.2014.0074.

Snethen G, McCormick BP, Van Puymbroeck M: Community involvement, planning and coping skills: Pilot outcomes of a recreational-therapy intervention for adults with schizophrenia. Disabil Rehabil. 2012; 34(18): 1575-1584. doi:10.3109/09638288.2011.650315.

Kovács Z, Kis R, Rózsa S, et al.: Animal-assisted therapy for middle-aged schizophrenic patients living in a social institution. A pilot study. Clin Rehabil. 2004; 18(5): 483-486. doi:10.1191/0269215504cr765oa.

Barker SB, Dawson KS: The effects of animal-assisted therapy on anxiety ratings of hospitalized psychiatric patients. Psychiatr Serv. 1998; 49(6): 797-801. doi:10.1176/ps.49.6.797.

Oh Y, Park S, Ahn B: Assessment of the psychopathological effects of a horticultural therapy program in patients with schizophrenia. Complement Ther Med. 2018; 36: 54-58.

Eum E-Y, Kim H-S: Effects of a horticultural therapy program on self-efficacy, stress response, and psychiatric symptoms in patients with schizophrenia. J Korean Acad Psychiatr Ment Heal Nurs. 2016; 25(1): 48-57.

Varambally S, Gangadhar B, Thirthalli J, et al.: Therapeutic efficacy of add-on yogasana intervention in stabilized outpatient schizophrenia: Randomized controlled comparison with exercise and waitlist. Indian J Psychiatry. 2012; 54(3): 227-232. doi:10.4103/0019-5545.102414.

Khalsa SBS, Cohen L, McCall T, et al.: History, philosophy and practice of yoga. In Khalsa SBS, Cohen L, McCall T, et al. (eds.): The Principles and Practice of Yoga in Health Care. Edinburgh: Handspring Publishing, 2016.

Field T: Complementary therapies in clinical practice yoga clinical research review. Complement Ther Clin Pract. 2011; 17(1): 1-8. doi:10.1016/j.ctcp.2010.09.007.

Pascoe MC, Bauer IE: A systematic review of randomized control trials on the effects of yoga on stress measures and mood. J Psychiatr Res. 2015; 68: 270-282. doi:10.1016/j.jpsychires.2015.07.013.

Riley KE, Park CL: How does yoga reduce stress? A systematic review of mechanisms of change and guide to future inquiry. Health Psychol Rev. 2015; 9(3): 379-396.

Streeter CC, Gerbarg PL, Saper RB, et al.: Effects of yoga on the autonomic nervous system, gamma-aminobutyric- acid, and allostasis in epilepsy, depression, and post-traumatic stress disorder. Med Hypotheses. 2012; 78(5): 571-579. doi:10.1016/j.mehy.2012.01.021.

Menezes CB, Kiesow LG, Sperb W, et al.: Yoga and emotion regulation: A review of primary psychological outcomes and their physiological correlates. 2015; 8(1): 82-101.

Pilkington K, Kirkwood G, Rampes H, et al.: Yoga for depression: The research evidence. 2005; 89: 13-24. doi:10.1016/j.jad.2005.08.013.

Gangadhar BN, Varambally S: Yoga therapy for schizophrenia. Int J Yoga. 2012; 5: 85-92. doi:10.4103/0973-6131.98212.

Behere RV, Arasappa R, Jagannathan A, et al.: Effect of yoga therapy on facial emotion recognition deficits, symptoms and functioning in patients with schizophrenia. Acta Psychiatr Scand. 2011; 123(2): 147-153. doi:10.1111/j.1600-0447.2010.01605.x.

Duraiswamy G, Thirthalli J, Nagendra HR, et al.: Yoga therapy as an add-on treatment in the management of patients with schizophrenia—A randomized controlled trial. Acta Psychiatr Scand. 2007; 116(3): 226-232. doi:10.1111/j.1600-0447.2007.01032.x.

Jayaram N, Varambally S, Behere R: Effect of yoga therapy on plasma oxytocin and facial emotion recognition deficits in patients of schizophrenia. Indian J Psychiatry. 2013; 55(7): 409.

Bhatia T, Mazumdar S, Wood J, et al.: A randomized controlled trial of adjunctive yoga and adjunctive physical exercise training for cognitive dysfunction in schizophrenia. Acta Neuropsychiatr. 2017; 29(2): 102-114. doi:10.1017/neu.2016.42.

Paikkatt B, Singh AR, Singh PK, et al.: Efficacy of yoga therapy for the management of psychopathology of patients having chronic schizophrenia. Indian J Psychiatry. 2015; 57(4): 355-360. doi:10.4103/0019-5545.171837.

Paikkatt B, Singh A, Singh P, et al.: Efficacy of yoga therapy on subjective well-being and basic living skills of patients having chronic schizophrenia. Ind Psychiatry J. 2012; 21(2): 109-114.

Visceglia E, Lewis S: Yoga therapy as an adjunctive treatment for schizophrenia: A randomized, controlled pilot study. J Altern Complement Med. 2011; 17(7): 601-607.

Ikai S, Suzuki T, Uchida H, et al.: Effects of weekly one-hour Hatha yoga therapy on resilience and stress levels in patients with schizophrenia-spectrum disorders: An eight-week randomized controlled trial. J Altern Complement Med. 2014; 20(11): 823-830. doi:10.1089/acm.2014.0205.

Lavey R, Sherman T, Mueser K, et al.: The effects of yoga on mood in psychiatric inpatients. Psychiatr Rehabil J. 2005; 28(4): 399-402.

Sistig B, Lambrecht I, Friedman S: Journey back into body and soul—An exploration of mindful yoga with psychosis. Psychosis. 2015; 7(1): 25-36.

Ikai S, Uchida H, Suzuki T, et al.: Effects of yoga therapy on postural stability in patients with schizophrenia-spectrum disorders: A single-blind randomized controlled trial. J Psychiatr Res. 2013; 47(11): 1744-1750. doi:10.1016/J.JPSYCHIRES.2013.07.017.

Lin J, Chan SKW, Lee EHM, et al.: Aerobic exercise and yoga improve neurocognitive function in women with early psychosis. NPJ Schizophr. 2015; 1: 15047. doi:10.1038/npjschz.2015.47.

Xie J, Lin Y, Guo C, et al.: Study on influences of yoga on quality of life of schizophrenic inpatients. J Nurs. 2006; 13: 9-11.

Chen EYH, Lin J, Lee EHM, et al.: Yoga exercise for cognitive impairment in psychotic disorders. Schizophr Res. 2014; 153(suppl 1): S26. doi:10.1016/S0920-9964(12)70205-0.

Manjunath RB, Varambally S, Thirthalli J: Efficacy of yoga as an add-on treatment for in-patients with functional psychotic disorder. Indian J Psychiatry. 2013; 55(7): 374-378.

Mehling WE, Price C, Daubenmier JJ, et al.: The Multidimensional Assessment of Interoceptive Awareness (MAIA). PLoS One. 2012; 7(11): e48230. doi:10.1371/journal.pone.0048230.

Bohlmeijer E, Ten Klooster PM, Fledderus M, et al.: Psychometric properties of the five facet mindfulness questionnaire in depressed adults and development of a short form. Assessment. 2011; 18(3): 308-320. doi:10.1177/1073191111408231.

McAuley E, Courneya KS: The Subjective Exercise Experiences Scale (SEES): Development and preliminary validation. J Sport Exerc Psychol. 1994; 16: 163-177. Available at https://journals-humankinetics-com.libproxy.clemson.edu/doi/pdf/10.1123/jsep.16.2.163. Accessed June 20, 2018.

Sistig B, Friedman S, McKenna B: Mindful yoga as an adjunct treatment for forensic inpatients: A preliminary evaluation. J Forens Psychiatry Psychol. 2015; 26(6): 824-846.

Park CL, Groessl E, Maiya M, et al.: Comparison groups in yoga research: A systematic review and critical evaluation of the literature. Complement Ther Med. 2014; 22(5): 920-929. doi:10.1016/j.ctim.2014.08.008.

Cramer H, Ward L, Saper R, et al.: The safety of yoga: A systematic review and meta-analysis of randomized controlled trials. Am J Epidemiol. 2015; 182(4): 281-293.




DOI: http://dx.doi.org/10.5055/ajrt.2018.0160

Refbacks

  • There are currently no refbacks.
This site uses cookies to maintain session information critical to the user's experience and environment on this system. Click "Accept Cookies" to continue.
For more details please visit our privacy statement at: Privacy & GDPR